Development and Validation of a Novel Prognostic Model for Endometrial Cancer Based on Clinical Characteristics

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249.33538338
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. doi:10.3322/caac.2149230207593
   PubMed Web of Science ®Google Scholar
• Torre LA, Islami F, Siegel RL, Ward EM, Jemal A. Global cancer in women: burden and trends. Cancer Epidemiol Biomarkers Prev. 2017;26:444–457. doi:10.1158/1055-9965.EPI-16-085828223433
   PubMed Web of Science ®Google Scholar
• Lortet-Tieulent J, Ferlay J, Bray F, Jemal A. International patterns and trends in endometrial cancer incidence, 1978–2013. J Natl Cancer Inst. 2018;110:354–361. doi:10.1093/jnci/djx21429045681
   PubMedGoogle Scholar
• Koh WJ, Abu-Rustum NR, Bean S, et al. Uterine neoplasms, version 1.2018, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2018;16:170–199. doi:10.6004/jnccn.2018.000629439178
   PubMed Web of Science ®Google Scholar
• Colombo N, Creutzberg C, Amant F, et al. ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up. Ann Oncol. 2016;27:16–41. doi:10.1093/annonc/mdv48426634381
   PubMed Web of Science ®Google Scholar
• Okuma K, Yamashita H, Kawana K, Nakagawa S, Oda K, Nakagawa K. Advanced age is a significant determinant of poor prognosis in patients treated with surgery plus postoperative radiotherapy for endometrial cancer. J Obstet Gynaecol Res. 2010;36:757–763. doi:10.1111/j.1447-0756.2010.01202.x20666941
   PubMed Web of Science ®Google Scholar
• Raglan O, Kalliala I, Markozannes G, et al. Risk factors for endometrial cancer: an umbrella review of the literature. Int J Cancer. 2019;145:1719–1730. doi:10.1002/ijc.3196130387875
   PubMed Web of Science ®Google Scholar
• Modesitt SC, van Nagell JR. The impact of obesity on the incidence and treatment of gynecologic cancers: a review. Obstet Gynecol Surv. 2005;60:683–692. doi:10.1097/01.ogx.0000180866.62409.0116186785
   PubMed Web of Science ®Google Scholar
• Scharl S, Gerken M, Sprötge T, et al. Comparison of survival outcomes and effects of therapy between subtypes of high-grade endometrial cancer – a population-based study. Acta Oncologica. 2021;60:1–7.33412980
   PubMed Web of Science ®Google Scholar
• Han KH, Kim HS, Lee M, Chung HH, Song YS. Prognostic factors for tumor recurrence in endometrioid endometrial cancer stages IA and IB. Medicine (Baltimore). 2017;96:e6976. doi:10.1097/MD.000000000000697628538399
   PubMed Web of Science ®Google Scholar
• Frederick PJ, Straughn JM. The role of comprehensive surgical staging in patients with endometrial cancer. Cancer Control. 2009;16:23–29. doi:10.1177/10732748090160010419078926
   PubMed Web of Science ®Google Scholar
• Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I. Endometrial cancer. Lancet. 2005;366:491–505. doi:10.1016/S0140-6736(05)67063-816084259
   PubMed Web of Science ®Google Scholar
• Deng F, Mu J, Qu C, et al. A novel prognostic model of endometrial carcinoma based on clinical variables and oncogenomic gene signature. Front Mol Biosci. 2020;7:587822. doi:10.3389/fmolb.2020.58782233490103
   PubMed Web of Science ®Google Scholar
• Prat J. Prognostic parameters of endometrial carcinoma. Hum Pathol. 2004;35:649–662. doi:10.1016/j.humpath.2004.02.00715188130
   PubMed Web of Science ®Google Scholar
• Kolehmainen A, Pasanen A, Tuomi T, Koivisto-Korander R, Bützow R, Loukovaara M. Clinical factors as prognostic variables among molecular subgroups of endometrial cancer. PLoS One. 2020;15:e0242733. doi:10.1371/journal.pone.024273333232359
   PubMed Web of Science ®Google Scholar
• Braun MM, Overbeek-Wager EA, Grumbo RJ. Diagnosis and management of endometrial cancer. Am Fam Physician. 2016;93:468–474.26977831
   PubMed Web of Science ®Google Scholar
• Singh N, Hirschowitz L, Zaino R, et al. Pathologic prognostic factors in endometrial carcinoma (other than tumor type and grade). Int J Gynecol Pathol. 2019;38(Suppl 1):S93–S113. doi:10.1097/PGP.000000000000052430550486
   PubMed Web of Science ®Google Scholar
• Uharcek P. Prognostic factors in endometrial carcinoma. J Obstet Gynaecol Res. 2008;34:776–783. doi:10.1111/j.1447-0756.2008.00796.x18958927
   PubMed Web of Science ®Google Scholar
• Kandoth C, Schultz N, Cherniack AD, et al. Integrated genomic characterization of endometrial carcinoma. Nature. 2013;497:67–73. doi:10.1038/nature1211323636398
   PubMed Web of Science ®Google Scholar
• Alektiar KM, Venkatraman E, Abu-Rustum N, Barakat RR. Is endometrial carcinoma intrinsically more aggressive in elderly patients? Cancer. 2003;98:2368–2377. doi:10.1002/cncr.1183014635071
   PubMed Web of Science ®Google Scholar
• Secord AA, Hasselblad V, Von Gruenigen VE, et al. Body mass index and mortality in endometrial cancer: a systematic review and meta-analysis. Gynecol Oncol. 2016;140:184–190. doi:10.1016/j.ygyno.2015.10.02026524722
   PubMed Web of Science ®Google Scholar
• Abu-Rustum NR, Zhou Q, Gomez JD, et al. A nomogram for predicting overall survival of women with endometrial cancer following primary therapy: toward improving individualized cancer care. Gynecol Oncol. 2010;116:399–403. doi:10.1016/j.ygyno.2009.11.02720022094
   PubMed Web of Science ®Google Scholar
• von Gruenigen VE, Tian C, Frasure H, Waggoner S, Keys H, Barakat RR. Treatment effects, disease recurrence, and survival in obese women with early endometrial carcinoma: a Gynecologic Oncology Group study. Cancer. 2006;107(12):2786–2791. doi:10.1002/cncr.2235117096437
   PubMed Web of Science ®Google Scholar
• Arem H, Irwin ML. Obesity and endometrial cancer survival: a systematic review. Int J Obes (Lond). 2013;37(5):634–639. doi:10.1038/ijo.2012.9422710929
   PubMed Web of Science ®Google Scholar
• Creasman WT, Odicino F, Maisonneuve P, et al. Carcinoma of the corpus uteri. FIGO 26th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet. 2006;95(Suppl 1):S105–S143. doi:10.1016/S0020-7292(06)60031-3
   PubMed Web of Science ®Google Scholar
• Ramirez PT, Frumovitz M, Pareja R, et al. Minimally invasive versus abdominal radical hysterectomy for cervical cancer. N Engl J Med. 2018;379:1895–1904. doi:10.1056/NEJMoa180639530380365
   PubMed Web of Science ®Google Scholar
• Melamed A, Margul DJ, Chen L, et al. Survival after minimally invasive radical hysterectomy for early-stage cervical cancer. N Engl J Med. 2018;379:1905–1914. doi:10.1056/NEJMoa180492330379613
   PubMed Web of Science ®Google Scholar
• Galaal K, Donkers H, Bryant A, Lopes AD. Laparoscopy versus laparotomy for the management of early stage endometrial cancer. Cochrane Database Syst Rev. 2018;10(10):CD006655. doi:10.1002/14651858.CD006655.pub330379327
   PubMed Web of Science ®Google Scholar
• Frumovitz M, Escobar P, Ramirez PT. Minimally invasive surgical approaches for patients with endometrial cancer. Clin Obstet Gynecol. 2011;54(2):226–234. doi:10.1097/GRF.0b013e318218637d21508692
   PubMed Web of Science ®Google Scholar
• Orezzoli JP, Sioletic S, Olawaiye A, Oliva E, Del Carmen MG. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion. Gynecol Oncol. 2009;113:316–323. doi:10.1016/j.ygyno.2009.03.00719345400
   PubMed Web of Science ®Google Scholar
• Homesley HD. Revised 1988 International Federation of Gynecology and Obstetrics staging systems for endometrial and vulvar cancer: an assessment. Clin Obstet Gynecol. 1992;35:89–94. doi:10.1097/00003081-199203000-000121544252
   PubMed Web of Science ®Google Scholar
• Fan Y, Li X, Tian L, Wang J. Identification of a metabolism-related signature for the prediction of survival in endometrial cancer patients. Front Oncol. 2021;11:630905. doi:10.3389/fonc.2021.63090533763366
   PubMed Web of Science ®Google Scholar
• Wright JD, Fiorelli J, Schiff PB, et al. Racial disparities for uterine corpus tumors: changes in clinical characteristics and treatment over time. Cancer. 2009;115:1276–1285. doi:10.1002/cncr.2416019204905
   PubMed Web of Science ®Google Scholar